These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2474060)

  • 1. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
    Stoter G; Koopman A; Vendrik CP; Struyvenberg A; Sleyfer DT; Willemse PH; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
    J Clin Oncol; 1989 Aug; 7(8):1099-104. PubMed ID: 2474060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
    Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
    Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of testicular cancer: a new and improved model.
    Einhorn LH
    J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
    Vogelzang NJ; Torkelson JL; Kennedy BJ
    Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
    Stoter G; Vendrik CP; Struyvenberg A; Sleyfer DT; Vriesendorp R; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
    Cancer; 1984 Oct; 54(8):1521-4. PubMed ID: 6206937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
    Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
    J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin.
    Hansen SW
    Dan Med Bull; 1992 Oct; 39(5):391-9. PubMed ID: 1385050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of disseminated testicular cancer.
    Einhorn LH
    Acta Urol Belg; 1985; 53(2):411-27. PubMed ID: 2409784
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria].
    Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Watanabe H; Iwamoto N; Yamazaki S; Hiratake Y; Maegawa M
    Hinyokika Kiyo; 1997 Aug; 43(8):561-6. PubMed ID: 9310778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
    Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
    J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of disseminated germ cell tumors.
    Einhorn LH
    Cancer; 1987 Aug; 60(3 Suppl):570-3. PubMed ID: 2439185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up.
    Roth BJ; Greist A; Kubilis PS; Williams SD; Einhorn LH
    J Clin Oncol; 1988 Aug; 6(8):1239-47. PubMed ID: 2457658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
    Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
    Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cured of testicular cancer; does life just go on?].
    Koopman A; Vendrik CP; Sleyfer DT; van Oosterom AT; ten Bokkel Huinink WW; Stoter G
    Ned Tijdschr Geneeskd; 1990 Jan; 134(1):23-5. PubMed ID: 1688648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer.
    Fosså SD; Lehne G; Heimdal K; Theodorsen L
    Oncology; 1995; 52(4):300-5. PubMed ID: 7539902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Critical analysis of the efficacy and toxicity of current chemotherapy in advanced non-seminoma testicular cancer: 3 years' experience].
    Germa Lluch JR; Marcuello Gaspar E; Badía Canto A; Dorca Ribugent J; Oltra Juste I; Arcusa Lanza A; Gallén Castillo M; Mila López JA
    Actas Urol Esp; 1984; 8(1):53-8. PubMed ID: 6202110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.